Expertise.
Annex 1 Consulting.
Ensure that your processes comply with the new Annex 1 requirements for sterile products and are GMP-compliant.
Compliant?
Do you meet all regulatory requirements of the current Annex 1 guidelines for sterile products?
Efficient?
Optimize your manufacturing processes for sterile medicinal products in accordance with current GMP requirements.
Secure?
Minimize risks and ensure continuous compliance with GMP requirements.
Annex 1 Compliance advice.
Our Annex 1 consulting supports you in complying with the new GMP guidelines for sterile drug production and helps you to adapt and optimize your processes.
GMP audits are a crucial step in ensuring compliance with the current Annex 1 requirements. Our experts will guide you through the entire audit process - from the preparation phase to the successful inspection by the authorities. Through tailor-made solutions, we support you in optimizing your processes, creating documentation and implementing a robust quality system for sterile products.
Our services include:
- Audit preparation & strategy development: We create individual strategies for preparing for Annex 1 GMP inspections.
- Conducting internal audits: Our experts carry out audits to evaluate your processes and identify necessary improvements.
- Follow-up & continuous improvement: We support you in the implementation of corrective measures and the continuous optimization of your quality system for sterile products.
Ensure your GMP compliance according to Annex 1.
Our expertise in Annex 1 compliance.
Our Annex 1 consulting covers all requirements of the current GMP regulations and offers you tailor-made solutions to optimize your sterile production and ensure GMP compliance.
Gap analysis and risk management.
- Carrying out comprehensive gap analyses to ensure compliance with the new Annex 1 requirements
- Development of a risk management approach to identify critical vulnerabilities
- Implementation of measures to minimize risks
Aseptic Process Validation.
- Validation and optimization of aseptic processes in accordance with Annex 1 guidelines
- Development and implementation of process optimizations to improve sterile production
- Support for continuous monitoring and validation
Environmental monitoring
monitoring.
-
Development and optimization of monitoring
processes for cleanrooms and sterile production environments - Ensuring compliance with all environmental guidelines and regulatory requirements
- Training employees to implement Annex 1 requirements
Successful Annex 1 projects.
Our successful Annex 1 compliance projects show how we have helped companies meet the stringent requirements of sterile drug production.
Annex 1 compliance in a global pharmaceutical company
Compliance for Annex 1 in a medium-sized biotech company
Challenge.
A global pharmaceutical company had to adapt its sterile production facility to the new Annex 1 guidelines without interrupting ongoing production.
Measures.
- Carrying out a comprehensive gap analysis to identify critical weaknesses
- Development of a new validation process for sterile production
- Implementation of an optimized monitoring strategy for cleanrooms
Results.
- The company met all GMP requirements within 6 months
- Reduction of contamination risks through improved cleanroom monitoring
Success.
The company was able to fully implement the Annex 1 requirements and continue production without any delays.
Meet the requirements of Annex 1.
Our Annex 1 service portfolio.
Our Annex 1 consultancy offers you customized solutions for the preparation, implementation and follow-up of audits to ensure GMP compliance in sterile pharmaceutical production.
The monitoring of cleanrooms is one of the key requirements of the new Annex 1 guidelines. We support you in developing a risk-based environmental monitoring strategy that meets all the requirements of the EU GMP Annex 1 guideline. In this way, we ensure that your monitoring processes fully capture both live and non-living particles and that all relevant data can be analyzed continuously and in real time.
The integration of new technologies such as single-use systems (SUS), restricted access barrier systems (RABS) and isolators is a central component of the current Annex 1 guidelines. Our experts will support you in seamlessly integrating these technologies into your production processes in accordance with the regulatory requirements of the European Medicines Agency (EMA ) in order to minimize contamination risks and at the same time increase the efficiency of your sterile production processes.
Another important part of the Annex 1 requirements is the strict adherence to and validation of aseptic processes, including the performance of filter integrity tests (Pre-use Post-sterilization Integrity Testing - PUPSIT). We support you in implementing reliable sterilization techniques and validating them comprehensively in accordance with the requirements of the Pharmaceutical Inspection Co-operation Scheme (PIC/S) and the EU GMP guidelines
The current Annex 1 guidelines place high demands on the qualifications and regular training of personnel in class A and B cleanrooms. Our tailor-made training programs ensure that your employees are always informed about the latest regulatory specifications and requirements. This includes, in particular, training on the correct use and disinfection of cleanroom garments and on behavior in sterile environments in accordance with the recommendations of the WHO GMP Guidelines.
A robust pharmaceutical quality system is essential for compliance with the current Annex 1 guidelines. Our experts will support you in developing and implementing a comprehensive contamination control strategy (CCS) to identify and manage all potential contamination risks. In this way, you ensure seamless quality assurance and meet the requirements of the current Annex 1 guideline.
The qualification of cleanrooms and production facilities forms a crucial basis for GMP-compliant sterile production. We provide you with comprehensive support in the planning, implementation and documentation of all qualification measures. In this way, we ensure that your production facilities and equipment fully comply with the regulatory requirements of the current EU GMP guidelines.
The safe and controlled handling of starting materials and packaging materials is key to avoiding contamination in sterile manufacturing processes. Our experts help you to establish suitable acceptance, storage and control processes and support you in the systematic qualification of your suppliers in order to fully comply with the requirements of Annex 1 and the EU GMP guideline.
Sterilization processes are a critical factor for product safety and quality. Our specialists support you in the selection, implementation and validation of suitable sterilization methods in accordance with the requirements of the current Annex 1 guidelines. Our advice ensures that your sterilization processes meet the highest GMP standards at all times.
Media fill studies are a central component of aseptic process validation and an essential element of the Annex 1 directive. Our consultants support you in the planning, implementation and analysis of media fill studies in order to effectively validate your aseptic processes and meet the regulatory requirements of EU GMP Annex 1.
Ensure your GMP compliance for sterile medicinal products.
Annex 1 - Related topics for the implementation of cleanroom and hygiene standards.
These supplementary services support you in complying with the latest requirements for aseptic processes: